MultiValent Biotherapies, Inc.

CIK 2107846 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for MultiValent Biotherapies, Inc..

Recent SEC filings

FiledFormAccession number
Mar 2, 2026D0002107846-26-000002
Feb 27, 2026D0002107846-26-000001